Comparison of bathophenanthroline sulfonate and ferene as chromogens in colorimetric measurement of low hepatic iron concentration.
We used samples of a frozen Wistar rat liver for quality control and determination of reliability criteria of both assays. We compared the results obtained with the two chromogens on 66 liver biopsies from patients with chronic liver diseases hospitalized in the Department of Hepatogastroenterology of the Pitie-Salpetriere Hospital. The clinical diagnoses of these patients are summarized in Table 1. We determined the CV for HIC measurements on two separate samples from the same liver specimen for each chromogen on 38 human liver biopsies. Histologic iron scoring was according to the method of Deugnier et al. (9); among the 66 biopsies, 20 had no stainable iron (score of 0), and the 46 others exhibited iron overload (score [greater than or equal to] 6). Biopsies were fixed in 40 g/L formaldehyde and embedded in paraffin as part of routine histologic processing for better preservation and transport.
Paraffin-embedded tissues were heated at 60[degrees]C to remove the paraffin and washed in three successive baths of xylene followed by three baths of ethanol. Liver samples were dried at 120[degrees]C for 24 h and weighed on a microbalance with 0.01 mg precision. The mean dry weight (dw) of the liver samples was 1 mg (SD, 0.4 mg; range; 0.5-2.5 mg). Liver samples were digested with an equivolume mixture of sulfuric acid and nitric acid for 5-8 min over a low flame. The working solutions were prepared by adding 10 mL of [H.sub.2]O (10). Samples of thawed rat liver were dried, weighed, and treated as described above.
HIC was measured according to the colorimetric method described by Barry and Sherlock (6). The iron in 3 mL of each working solution was reduced with 50 [micro]L of thioglycolic acid (Sigma Aldrich) and 2.5 mL of an acetic acid-acetate buffer (Merck Eurolab) at pH 4.5, which is optimal for the reduction of ferric to ferrous iron and for absorbance measurements of iron complexed with bathophenanthroline sulfonate (4,7-diphenyl-1,10-phenanthroline disulfonic acid), disodium salt or ferene 13-(2-pyridyl)-5,6-bis(2[5-furyl sulfonic acid])-1,2,4-triazine} (11). Samples were then incubated with 0.4 mL of bathophenanthroline sulfonate or ferene (3 [micro]mol/L; Sigma Aldrich) for 1 h at 37[degrees]C. The absorbances were read against a blank on a Beckman DU 640 spectrophotometer at 535 nm for bathophenanthroline or at 592 mn for ferene as the chromogen.
All chemical reagents were iron-free grade. The absorbance of the blank had to be <0.006 to verify the absence of contaminating iron. A calibration curve was constructed, using serial dilutions of a solution of 180 [micro]mol/L ferrous ammonium sulfate (Merck Eurolab). Results were expressed in [micro]mol/g dw of liver tissue. When we used bathophenanthroline sulfonate as chromogen, HIC was [less than or equal to] 20 [micro]mol/g dw for a histologic iron score of 0.
We performed regression analysis using the method of Passing and Bablok (12). The differences between the chromogen-related iron measurements in relation to the mean of the two paired values were estimated by Bland-Altman plots (13).
The within-day reproducibility of the method was evaluated on the same rat liver tissue. Ten liver samples were treated as described above. The iron content was assayed twice with each chromogen on the different working solutions. The CVs were 11% (mean [+ or -] SD iron concentration, 13.2 [+ or -] 1.4 [micro]mol/g dw; range, 11.5-15.6 [microl]mol/g dw) and 9.4% (13.4 [+ or -] 1.3 [micro]mol/g dw; range, 11.5-15.4 [micro]mol/g dw) for bathophenanthroline and ferene, respectively. The day-to-day reproducibility was evaluated on 15 samples of rat liver tissue. The CVs were 13% (12.2 [+ or -] 1.5 [micro]mol/g dw; range, 8.5-14.3 [micro]mol/g dw) and 12% (11.7 [+ or -] 1.4) [micro]mol/g dw; range 8.6-14.0 [micro]mol/g dw) for bathophenanthroline and ferene, respectively.
For 11 patients with a histologic score of 0 (iron concentration, 4.3-15.0 [micro]mol/g dw), HIC was determined with each chromogen in two different samples from the same liver biopsy (1.32 [+ or -] 0.45 mg dw). The SD for a single iron determination gave CVs of 9.8% and 11% for the bathophenanthroline and ferene methods, respectively. For 27 patients with a histologic iron score [greater than or equal to] 6 (iron concentration, 14.0-89.0 [micro]mol/g dw) tested in duplicate (dry weight of liver samples, 0.92 [+ or -] 0.32 mg) the SD for iron determination gave CVs of 15% for both the bathophenanthroline and ferene methods.
A linear calibration was verified for the two chromogens for iron concentrations of 0.3-30.0 [micro]mol/L. The detection limit of the assay measured on 10 blank replicates was 0.30 [micro]mol/L for bathophenanthroline and 0.16 [micro]mol/L for ferene. The sensitivity of the assay, defined as the slope of the calibration curve, was 0.215 with bathophenanthroline and 0.333 with ferene. The intercept (absorbance) was 0.007 for bathophenanthroline and 0.008 for ferene.
The HIC of 66 patients with chronic liver disease was determined using the two chromogens. The correlation of the two methods was assessed by Passing-Bablok analysis. Comparison of the methods gave a slope of 1.00, an intercept of -1.00, and a correlation coefficient of 0.99. A Bland-Altman difference plot for the paired values is shown in Fig. 1. The differences between the paired values are shown on the y-axis, and the means are shown on the x-axis. The mean difference and the SD of the differences are depicted parallel to the x-axis. Fig. 1 shows that eight of the paired values were outside the 95% confidence interval. Four values were close to the lower limit of agreement (-3.0 vs -2.6), whereas the other four were close to the upper limit of agreement (5.0 and 6.0 vs 4.2).
Colorimetric methods for determination of hepatic iron content have been shown to be accurate and sensitive. The flameless atomic absorption spectrophotometry method has been described as sensitive, but it requires costly equipment. Recently, magnetic resonance imaging was shown to distinguish mild from severe iron overload in the range of 45-134 [micro]mol/g dw (14). However, at lower concentrations, variability and reproducibility of the method were not investigated. We previously reported the evaluation and validation of a colorimetric method described by Barry and Sherlock (6) with the aim of measuring low HIC (7). To improve the sensitivity of this colorimetric assay, we evaluated the performance of ferene as a chromogen. Indeed, ferene has a higher absorptivity than bathophenanthroline sulfonate (33 850 vs 22 369 L * [mol.sup.-1] * [cm.sup.-1]) and has been shown to be more sensitive in the determination of serum iron (11).
The CV for iron concentrations in duplicate specimens from liver samples from patients with a histologic score of 0 was slightly higher with ferene (11% vs 9.8%). Barry and Sherlock (6) reported a CV of 7.0%, but the dry weights of their liver samples were heavier. In specimens from patients with an histologic iron score [greater than or equal to] 6, the CVs for determination of HIC were comparable for ferene and bathophenanthroline.
The within-day reproducibility of the method, using rat liver samples, was better when ferene was used as the chromogen (9.4% vs 11%) and was comparable to other colorimetric assays (15). The day-to-day CV was better when ferene was used. Comparison of the two methods by Passing-Bablok analysis showed that results obtained with the two chromogens were correlated. The Bland-Altman difference plot (Fig. 1) showed that eight of the paired values were outside of the 95% confidence interval (-2.6 and 4.2). These values fell nearly within the limits of agreement, and medical acceptance remained possible.
[FIGURE 1 OMITTED]
The determination of low HIC with ferene gave better sensitivity (0.333 vs 0.215) and a lower detection limit (0.15 vs 0.30 [micro]mol/L) than with bathophenanthroline. Moreover, this chromogen is less expensive than bathophenanthroline.
In conclusion, ferene, which is less expensive than bathophenanthroline sulfonate, slightly improves the sensitivity of the colorimetric measurement of low HIC. Ferene can beneficially replace bathophenanthroline sulfonate in HIC determinations as recommended by the ICSH for serum iron (8).
(1.) Britton RS, Bacon BR, Ricknagel RO. Lipid peroxidation and associated hepatic organelle dysfunction in iron overload. Chem Phys Lipids 1987;45: 207-39.
(2.) Olynyk JK, Reddy KR, Di Bisceglie AM, Jeffers U, Parker TI, Radick JI, et al. Hepatic iron concentration as a predictor of response to interferon a therapy in chronic hepatitis C. Gastroenterology 1995;108:1104-9.
(3.) Kaji K, Nakanuma Y, Harada K, Sakai A, Kanebo S, Kobayashi K. Hemosiderin deposition in portal endothelial cells is a histological marker predicting poor response to interferon-a therapy in chronic hepatitis C. Pathol Int 1997;47:347-52.
(4.) International Committee for Standardization in Hematology. Proposed recommendations for measurement of serum iron in human blood. Am J Clin Pathol 1971;56:543-5.
(5.) Iron Panel of the International Committee for Standardization in Haematology. Recommendations for measurement of serum iron in human blood. Br J Haematol 1978;38:291-4.
(6.) Barry M, Sherlock S. Measurement of liver-iron concentration in needlebiopsy specimens. Lancet 1971;i:100-3.
(7.) Imbert-Bismut F, Charlotte F, Turlin B, Khalil L, Piton A, Brissot P, et al. Low hepatic iron concentration: evaluation of two complementary methods, colorimetric assay and iron histological scoring. J Clin Pathol 1999;52: 430-4.
(8.) Iron Panel of the International Committee for Standardization in Haematology. Revised recommendations for the measurements of the serum iron in human blood. Br J Haematol 1990;75:615-6.
(9.) Deugnier YM, Loreal O, Turlin B, Guyader D, Jouanolle H, Moirand R, et al. Liver pathology in genetic hemochromatosis: a review of 135 homozygous cases and their bioclinical correlations. Gastroenterology 1992;102: 2050-9.
(10.) Barry M. Determination of chelated iron in the urine. J Clin Pathol 1968;21: 166-8.
(11.) Derman DP, Green A, Bothwell TH, Graham B, McNamara L, MacPhail AP, et al. A systematic evaluation of bathophenanthroline, ferrozin and ferene in an ICSH-based method for the measurement of serum iron. Ann Clin Biochem 1989;26:144-7.
(12.) Passing H, Bablok W. Comparison of several regression procedures for method comparison studies and determination of sample sizes. Application of linear regression procedures for method comparison studies in clinical chemistry. J Clin Chem Clin Biochem 1984;22:431-45.
(13.) Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;i:307-10.
(14.) Bonkovsky HL, Rubin RB, Cable EE, Davidoff A, Pels Rijcken TH, Stark DD. Hepatic iron concentration: noninvasive estimation by means of MR imaging techniques. Radiology 1999;212:227-34.
(15.) Kreeftenberg HG, Koopman BJ, Huizenga JR, Van Vilsteren T, Wolthers BG, Gips CH. Measurement of iron in liver biopsies--a comparison of three analytical methods. Clin Chim Act 1984;144:255-62.
Laurence Pieroni, Lina Khalil, Frederic Charlotte, Thierry Poynard, Annie Piton, Bernard Hainque, and Francoise Imbert-Bismuth * ( Laboratoire de Biochimie B, Service d'Anatomopathologie, and  Service d'Hepatogastroenterologie, Groupe Hospitalier Pitie-Salpetriere, 47 Boulevard de l'Hopital, F 75651 Paris Cedex 13, France; * author for correspondence: fax 33-0142-16-20-33, e-mail email@example.com)
Table 1. Clinical diagnoses of patients with chronic hepatic disorders. Histologic iron score Pathology 0 [greater than or equal to] 6 Hepatitis C only 15 30 Hepatitis C 1 HIV 2 5 Hepatitis C 1 hepatitis B 0 2 Hepatitis C 1 alcoholism 1 0 Hepatitis B only 1 1 Alcoholism 0 1 Hemochromatosis 0 2 Dysmetabolic syndrome 1 1 Other 0 4 Total 20 46
|Printer friendly Cite/link Email Feedback|
|Title Annotation:||Technical Briefs|
|Author:||Pieroni, Laurence; Khalil, Lina; Charlotte, Frederic; Poynard, Thierry; Piton, Annie; Hainque, Berna|
|Date:||Nov 1, 2001|
|Previous Article:||Effects of glucocorticoid immunosuppression on serum cystatin C concentrations in renal transplant patients.|
|Next Article:||Osteoprotegerin in serum as a novel marker of bone metastatic spread in prostate cancer.|